Expression of a chondroitin sulfate proteoglycan, versican (PG-M), during development of rat cornea

Current Eye Research

Volumn 30, Issue 6, 2005, Pages 455-463

  Koga, Takahisa ^a   Inatani, Masaru ^b   Hirata, Akira ^a   Inomata, Yasuya ^a   Zako, Masahiro ^c   Kimata, Koji ^c   Oohira, Atsuhiko ^d   Gotoh, Tomomi ^a   Mori, Masataka ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

Author keywords

Corneal development; Hyaluronan; PG M versican; Proteoglycans

Indexed keywords

AGGRECAN; BIGLYCAN; DECORIN; GLYCOPROTEIN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; PROTEOCHONDROITIN SULFATE; PROTEOKERATAN SULFATE; UNCLASSIFIED DRUG; VERSICAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOTINYLATION; COMPLEX FORMATION; CONTROLLED STUDY; CORNEA; DOT HYBRIDIZATION; EYE DEVELOPMENT; IMMUNOHISTOCHEMISTRY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGING; ANIMALS; ANIMALS, NEWBORN; CORNEA; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VERSICANS;

EID: 21844451940     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680590959376     Document Type: Article

References (39)

1. Hassell JR, Cintron C, Kublin C, Newsome DA. Proteoglycan changes during restoration of transparency in corneal scars. Arch Biochem Biophys. 1983;222:362-369.
2. Blochberger TC, Vergnes JP, Hempel J, Hassell JR. cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J Biol Chem. 1992;267:347-352.
3. Corpuz LM, Funderburgh JL, Funderburgh ML, Bottomley GS, Prakash S, Conrad G W. Molecular cloning and tissue distribution of keratocan. Bovine corneal keratan sulfate proteoglycan 37A. J Biol Chem. 1996;271:9759-9763.
4. Funderburgh JL, Corpuz LM, Roth MR, Funderburgh, ML, Tasheva, ES, Conrad GW. Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin. J Biol Chem. 1997;272:28089-28095.
5. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998;141:1277-1286.
6. Pellegata NS, Dieguez-Lucena JL, Joensuu T, Lau S, Montgomery KT, Krahe R, Kivela T, Kucherlapati R, Forsius H, de la Chapelle A. Mutations in KERA, encoding keratocan, cause cornea plana. Nat Genet. 2000;25:91-95.
7. Blochberger TC, Cornuet PK, Hassell JR. Isolation and partial characterization of lumican and decorin from adult chicken corneas. A keratan sulfate-containing isoform of decorin is developmentally regulated. J Biol Chem. 1992;267:20613-20619.
8. Zhan Q, Burrows R, Cintron C. Cloning and in situ hybridization of rabbit decorin in corneal tissues. Invest Ophthalmol Vis Sci. 1995;36:206-215.
9. Funderburgh JL, Hevelone ND, Roth MR, Funderburgh ML, Rodrigues MR, Nirankari, VS, Conrad GW. Decorin and biglycan of normal and pathologic human corneas. Invest Ophthalmol Vis Sci. 1998;39:1957-1964.
10. Lennon DP, Carrino DA, Baber MA, Caplan Al. Generation of a monoclonal antibody against avian small dermatan sulfate proteoglycan: immunolocalization and tissue distribution of PG-II (decorin) in embryonic tissues. Matrix. 1991;11:412-427.
11. Doane KJ, Ting WH, McLaughlin JS, Birk DE. Spatial and temporal variations in extracellular matrix of periocular and corneal regions during corneal stromal development. Exp Eye Res. 1996;62:271-283.
12. Yamagata M, Shinomura T, Kimata K. Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/aggrecan) in chick embryos. Anat Embryol (Berl). 1993;187:433-444.
13. Kimata K, Oike Y, Tani K, Shinomura T, Yamagata M, Uritani M, Suzuki S. A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo. J Biol Chem. 1986;261:13517-13525.
14. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBOJ. 1989;8:2975-2981.
15. Dours-Zimmermann MT, Zimmermann DR. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem. 1994;269:32992-32998.
16. Zako M, Shinomura T, Ujita M, Ito K, Kimata K. Expression of PG-M (V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues. J Biol Chem. 1995;270:3914-3918.
17. Zou K, Muramatsu H, Ikematsu S, Sakuma S, Salama RH, Shinomura T, Kimata K, Muramatsu T. A heparin-binding growth factor, midkine, binds to a chondroitin sulfate proteoglycan, PG-M/versican. Eur J Biochem. 2000;267:4046-4053.
18. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem. 1995;270:958-965.
19. Oohira A, Matsui F, Watanabe E, Kushima Y, Maeda N. Developmentally regulated expression of a brain specific species of chondroitin sulfate proteoglycan, neurocan, identified with a monoclonal antibody IG2 in the rat cerebrum. Neuroscience. 1994;60:145-157.
20. Yamamoto Y, Atoji Y, Oohira A, Suzuki Y. Immunohistochemical localization of chondroitin sulfate in the forestomach of the sheep. Eur J Histochem. 1995;39:265-272.
21. Asher R, Perides G, Vanderhaeghen JJ, Bignami A. Extracellular matrix of central nervous system white matter: demonstration of an hyaluronate-protein complex. J Neurosci Res. 1991;28:410-421.
22. Asher RA, Scheibe RJ, Keiser HD, Bignami A. On the existence of a cartilage-like proteoglycan and link proteins in the central nervous system. Glia. 1995;13:294-308.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
24. Koga T, Koshiyama Y, Gotoh T, Yonemura N, Hirata A, Tanihara H, Negi A, Mori M. Coinduction of nitric oxide synthase and arginine metabolic enzymes in endotoxin-induced uveitis rats. Exp Eye Res. 2002;75:659-667.
25. Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding properties from cartilage. Biochim Biophys Acta. 1979;578:281-289.
26. Fitzsimmons TD, Molander N, Stenevi U, Fagerholm P, Schenholm M, von Malmborg A. Endogenous hyaluronan in corneal disease. Invest Ophthalmol Vis Sci. 1994;35:2774-2782.
27. LeBaron RG, Zimmermann DR, Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem. 1992;267:10003-10010.
28. Zagris N. Extracellular matrix in development of the early embryo. Micron. 2001;32:427-438.
29. Shinomura T, Nishida Y, Ito K, Kimata K. cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem. 1993;268:14461-14469.
30. Perissinotto D, Iacopetti P, Bellina I, Doliana R, Colombatti A, Pettway Z, Bronner-Fraser M, Shinomura T, Kimata K, Morgelin M, et al. Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. Development. 2000;127:2823-2842.
31. Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci. 2002;22:2225-2236.
32. Pepose JS, Ubels, JL. The cornea. In: Hart WM Jr. Adler's Physiology of the Eye: Clinical Application, 9th ed. St. Louis: Mosby-Year Book, Inc.; 1992:47-48.
33. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development. 1995;121:2303-2312.
34. Kerr RS, Newgreen DF. Isolation and characterization of chondroitin sulfate proteoglycans from embryonic quail that influence neural crest cell behavior. Dev Biol. 1997;192:108-124.
35. Zimmermann DR, Dours-Zimmermann MT, Schubert M, Bruckner-Tuderman L. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol. 1994;124:817-825.
36. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, Briner J, Heitz PU, Zimmermann DR. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem. 1996;44:303-312.
37. Zhang Y, Cao L, Yang BL, Yang BB. The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs. J Biol Chem. 1998;273:21342-21351.
38. Zhang Y, Cao L, Kiani C, Yang BL, Hu W, Yang BB. Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs. J Cell Biochem. 1999;73:445-457.
39. Wu Y, Zhang Y, Cao L, Lee V, Zheng PS, Kiani C, Adams ME, Ang LC, Paiwand F, Yang BB. Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding J Biol Chem. 2001;276:14178-14186.